BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 216043)

  • 21. Prostaglandin modulation of the postnatal development of T and B lymphocytes in the spleens of newborn mice.
    Shibuya T; Izuchi K; Koga Y; Nomoto K; Shirakawa K
    Dev Comp Immunol; 1986; 10(3):419-28. PubMed ID: 3490412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of PGE2 and LTB4 on vicia villosa binding lymphocytes.
    Gualde N; Cook JM; Guibert F
    APMIS; 1988 Jun; 96(6):531-6. PubMed ID: 2840103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Similarities in cAMP responses between murine lymphoid cell lines and subsets of mouse lymphocytes.
    Box RJ; Portenier M; Staehelin M
    J Leukoc Biol; 1987 Aug; 42(2):144-9. PubMed ID: 3036989
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of prostaglandin E1 or E2 on the in vitro blastogenic response of lymphocytes from normal and tumor-bearing mice.
    Stylos WA; Lengel CR; Lyng PJ; Chirigos MA
    J Immunopharmacol; 1979; 1(2):195-217. PubMed ID: 553108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prolongation of the effects of gonadotrophins and prostaglandin E2 on ovarian cyclic AMP formation by inhibitors of protein synthesis.
    Bergh C; Ahrén K
    Acta Endocrinol (Copenh); 1980 Jun; 94(2):251-8. PubMed ID: 6158241
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The role of cultured thymic epithelium and dialyzable leukocyte extracts on the maturation process of T cell. Study of their effects on cyclic nucleotides levels in thymocytes].
    Tsuneta H
    Hokkaido Igaku Zasshi; 1984 Mar; 59(2):128-39. PubMed ID: 6086479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclic AMP as a mediator of prostaglandin E-induced suppression of human natural killer cell activity.
    Goto T; Herberman RB; Maluish A; Strong DM
    J Immunol; 1983 Mar; 130(3):1350-5. PubMed ID: 6185577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences in effect of isoproterenol stimulation on levels of cyclic AMP in human B and T lymphocytes.
    Niaudet P; Beaurain G; Bach MA
    Eur J Immunol; 1976 Nov; 6(11):834-6. PubMed ID: 187430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Calcium-mediated effects of calcitonin on cyclic AMP formation and lymphoblast proliferation in thymocyte populations exposed to prostaglandin E 1 .
    Whitfield JF; MacManus JP; Franks DJ; Braceland BM; Gillan DJ
    J Cell Physiol; 1972 Dec; 80(3):315-28. PubMed ID: 4346090
    [No Abstract]   [Full Text] [Related]  

  • 30. Serial changes in humoral and cellular immunity induced by prostaglandin E2 treatment of murine immune complex glomerulonephritis.
    McLeish KR; Stelzer GT; Eades DS; Cohen R; Wallace JH
    J Lab Clin Med; 1985 Nov; 106(5):517-23. PubMed ID: 2932513
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostaglandin E2 inhibits the activation of cloned T cell hybridomas.
    Makoul GT; Robinson DR; Bhalla AK; Glimcher LH
    J Immunol; 1985 Apr; 134(4):2645-50. PubMed ID: 2857750
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differences in Cyclic AMP Changes after Stimulation by Prostaglandins and Isoproterenol in Lymphocyte Subpopulations.
    Bach MA
    J Clin Invest; 1975 May; 55(5):1074-81. PubMed ID: 16695962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of human B cell responsiveness by prostaglandin E2.
    Simkin NJ; Jelinek DF; Lipsky PE
    J Immunol; 1987 Feb; 138(4):1074-81. PubMed ID: 3027169
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of cyclic AMP content of the rat myometrium: desensitization to isoproterenol, PGE2 and prostacyclin.
    Tougui Z; Do Khac L; Harbon S
    Mol Cell Endocrinol; 1980 Oct; 20(1):17-34. PubMed ID: 6254820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clonal heterogeneity of cyclic AMP responsiveness: a comparison of malignant murine lymphoid cell lines.
    Burchiel SW; Hanson K; Warner NL
    Int J Immunopharmacol; 1984; 6(1):35-42. PubMed ID: 6202649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prostaglandin E2 inhibits B lymphocyte activation by a cAMP-dependent mechanism: PGE-inducible regulatory proteins.
    Roper RL; Ludlow JW; Phipps RP
    Cell Immunol; 1994 Apr; 154(1):296-308. PubMed ID: 8131204
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of adenylate cyclase/cyclic AMP response by thyrotropin and prostaglandin E2 in cultured thyroid cells. 1. Negative regulation.
    Takasu N; Charrier B; Mauchamp J; Lissitzky S
    Eur J Biochem; 1978 Sep; 90(1):131-8. PubMed ID: 213269
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Quantitative interrelationships between the T- and B-cell populations of mouse lymphoid organs].
    Iarilin AA; Polushkina EF
    Tsitologiia; 1978 Jul; 20(7):802-7. PubMed ID: 308720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of prostaglandins and other drugs on the cyclic AMP content of cultured bone cells.
    Yu JH; Wells H; Ryan WJ; Lloyd WS
    Prostaglandins; 1976 Oct; 12(4):501-13. PubMed ID: 184495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prostaglandins and inflammation: enhancement of monocyte chemotactic responsiveness by prostaglandin E2.
    McClatchey W; Snyderman R
    Prostaglandins; 1976 Sep; 12(3):415-26. PubMed ID: 184494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.